Ownership history in XY Capital Ltd Β· 9 quarters on record
This page tracks every 13F SEC filing in which XY Capital Ltd reported a position in NETEASE INC (NTES). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price β sourced directly from SEC EDGAR 13F filings.
π XY Capital Ltd underperformed the S&P 500 by β3.1% annually on this NTES position. Timing score: 62% (5/8 decisions correct). Average cost basis: $93.00. Maximum drawdown during holding period: β0.0%.
β οΈ Trailed SPY by 3.1% ann. on this position.
8 quarters analyzed
β
Decent timing β more right than wrong on entries and exits.
5 of 8 add/trim decisions correct
Best entry: $90.06 (2023 Q2) Β· Worst: $100.51 (2025 Q1)
π No drawdown exceeding 20% during the holding period β exceptionally stable.
3 adds Β· 5 trims. π Predominantly trimming β distribution phase.
π Portfolio weight has been declining in recent quarters. Possible distribution phase.
Currently 0.14% of portfolio
β Based on quarterly 13F SEC filings and end-of-quarter closing prices. Timing score = accuracy of add/trim decisions vs next-quarter price direction. Alpha = mean quarterly excess return Γ 4 (annualised). Not investment advice.
As of 2025 Q4 β sorted by position size